| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |